The World Health Organization should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, as reported in the Financial Post.
Director General Tedros Adhanom Ghebreyesus said "nearly 5500 patients in 39 countries have so far been recruited into the Solidarity trial," he said, referring to clinical studies the agency is conducting, and "we expect interim results within the next two weeks."
The Solidarity Trial started out in five parts looking at possible treatment approaches to COVID-19, including standard care, remdesivir, hydroxychloroquine, lopinavir/ritonavir, and lopanivir/ritonavir combined with interferon.
Earlier this month, it stopped the arm testing hydroxychloroquine, after studies indicated it showed no benefit in those who have the disease, but more work is still needed to see whether it may be effective as a preventative medicine.
To read more NewsPoints articles, click here.